 CHERRY HILL, N.J., April 05, 2021 GLOBE NEWSWIRE -- Vyant Bio, Inc. the Company Nasdaq: VYNT, is a new force in drug discovery, focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery of therapeutics for biopharma partners as well as for the proprietary pipeline of the Company. Its newly formed Board of Directors comes from the disciplines of drug discovery and development, pharmaceuticals, and life science strategy and finance. The new board members bring decades of experience and leadership to help guide the Company in its focus on innovative and market leading drug discovery. 